Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627328 · ClinicalTrials.gov registry record
The Atrial High Rate Episodes in Pacemaker Patients
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 427
- Enrollment target
NCT00627328: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00627328 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 427 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00627328 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 427 participants
- Enrollment target
Study Summary
Prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2000-07 |
| Est. Completion | 2004-09 |
What the finished NCT00627328 record still lists
NCT00627328 is an observational study that tracks outcomes without assigning an intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00627328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00627328 about?
NCT00627328 is a clinical study titled "The Atrial High Rate Episodes in Pacemaker Patients". Prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT.
What is the current status of trial NCT00627328?
This trial is currently completed. The enrollment target is 427 participants. The study started on 2000-07. Estimated completion is 2004-09.
Who is sponsoring clinical trial NCT00627328?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia